Bayforest Capital’s Eastman Chemical EMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$40.9K Sell
610
-2,122
-78% -$155K 0.04% 662
2026
Q1
$209K Buy
2,732
+2,662
+3,803% +$192K 0.23% 111
2025
Q4
$4.47K Buy
+70
New +$4.31K ﹤0.01% 714
2025
Q2
Sell
-4,700
Closed -$414K 791
2025
Q1
$414K Buy
4,700
+4,360
+1,282% +$412K 0.18% 207
2024
Q4
$31K Buy
+340
New +$34.9K 0.04% 529

Other funds holding EMN

Bayforest Capital's EMN Position: Q2 2026 in Review

Bayforest Capital reduced its Eastman Chemical (EMN) stake by 78% in Q2 2026, selling an estimated $155K and leaving 610 shares worth $40.9K. The position accounts for 0.04% of the portfolio, ranked #662.

Bayforest Capital first reported a position in EMN in Q4 2024 and has held it in 5 quarters since. The position peaked at $414K in Q1 2025. 642 funds tracked by Wall St. Rank hold EMN as of Q2 2026.

  • Bayforest Capital held 610 shares of Eastman Chemical worth $40.9K as of Q2 2026.
  • Bayforest Capital sold 2,122 Eastman Chemical shares in Q2 2026, an estimated $155K.
  • Eastman Chemical made up 0.04% of Bayforest Capital's portfolio in Q2 2026, its #662 holding.
  • Bayforest Capital first reported a position in Eastman Chemical in Q4 2024 and has held it in 5 quarters since.
  • Bayforest Capital's Eastman Chemical position peaked at $414K in Q1 2025.
  • 642 funds tracked by Wall St. Rank held Eastman Chemical as of Q2 2026.

Based on Bayforest Capital's 13F filing for Q2 2026, filed 5 Aug 2026.